113 related articles for article (PubMed ID: 10647204)
1. [Antianginal effectiveness of regular isosorbide-5-mononitrate (monochinkwe retard) intake].
Golikov AP; Allenova IB; El'kina NS
Ter Arkh; 1999; 71(12):52-3. PubMed ID: 10647204
[No Abstract] [Full Text] [Related]
2. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
[TBL] [Abstract][Full Text] [Related]
3. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
Demchenko EA; Berezina AV; Panov AV
Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229
[No Abstract] [Full Text] [Related]
4. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
Demin AA; Aksenova EA
Klin Med (Mosk); 2005; 83(9):53-6. PubMed ID: 16279042
[TBL] [Abstract][Full Text] [Related]
6. [Autonomous pharmacodynamics of organic nitrates in patients with unstable angina].
Safronova ÉA; Mironova TF; Shadrina IM
Klin Med (Mosk); 2013; 91(7):32-8. PubMed ID: 24437167
[TBL] [Abstract][Full Text] [Related]
7. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
8. [Nitrates. The place in contemporary therapy of ischemic heart disease].
Martsevich SIu
Kardiologiia; 2005; 45(7):69-72. PubMed ID: 16091666
[No Abstract] [Full Text] [Related]
9. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
10. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
11. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
[No Abstract] [Full Text] [Related]
12. Pain scoring--a method for assessing acute antianginal therapy comparison of the response to acute sublingual administration of an isosorbide dinitrate tablet, isosorbide dinitrate spray and nitroglycerin spray in unstable angina.
Shotan A; Brill Z; Matetzky S; Shachar A; Feigenberger Z; Hod H; Kaplinsky E
Cardiology; 1998 Mar; 89(3):163-9. PubMed ID: 9570429
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary nitrates may avoid unnecessary angioplasty.
Lloyd G; Cooke R; Jackson G
Int J Clin Pract; 1997; 51(5):317. PubMed ID: 9489093
[No Abstract] [Full Text] [Related]
14. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
16. [The effect on painful and silent myocardial ischemia of the preparations Efox and Efox Long in patients with stenocardia of effort].
Belousov IuB; Egorova NA; Karasev AV; Upnitskiĭ AA
Ter Arkh; 1997; 69(9):45-7. PubMed ID: 9411825
[TBL] [Abstract][Full Text] [Related]
17. [Functional activity of platelet guanylate cyclase and cardiac hemodynamics in patients with chronic heart failure and relevant changes after treatment with isosorbide-5-mononitrate].
Ol'binskaia LI; Ushakova AV; Sizova ZhM
Ter Arkh; 1999; 71(9):77-9. PubMed ID: 10553632
[TBL] [Abstract][Full Text] [Related]
18. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
Arthur RM; Mehmel H
Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
[TBL] [Abstract][Full Text] [Related]
19. [A new antianginal preparation: isosorbide-5-mononitrate].
Martsevich SIu; Metelitsa VI; Slastnikova ID; Simkhaev LS; Egorov LV; Blagodatskikh SV
Kardiologiia; 1990 Oct; 30(10):44-6. PubMed ID: 2290270
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
Kurpesa M; Krzemińska-Pakuła M; Kedzia E; Trzos E; Musiał W; Peruga Z
Wiad Lek; 1994 Aug; 47(15-16):587-90. PubMed ID: 7716955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
